APTAMER INHIBITION OF THROMBUS FORMATION
    4.
    发明公开
    APTAMER INHIBITION OF THROMBUS FORMATION 审中-公开
    APTAMER对血栓形成的抑制作用

    公开(公告)号:EP2310054A2

    公开(公告)日:2011-04-20

    申请号:EP09807338.0

    申请日:2009-08-14

    摘要: Boronic acid-modified DNA-based aptamers can be selected to recognize fibrinogen through binding at a glycosylation site and thus are useful for probing the effect of glycosylation pattern changes on the ability for fibrinogen to mediate blood coagulation. In addition, the aptamers of the disclosure also have anticoagulation effects due to their binding to fibrinogen and its cleavage product fibrin. The present disclosure, therefore, encompasses methods for inhibiting fibrin coagulation with an aptamer capable of specifically binding to a glycosylation site of fibrinogen or fibrin. The disclosure further provides oligonucleotide aptamers comprising at least one nucleotide having a boronic acid thereon, where the aptamer is capable of selectively binding to a glycosylation site of fibrinogen, or the derivative thereof.

    摘要翻译: 可以选择硼酸修饰的基于DNA的适体通过在糖基化位点结合来识别纤维蛋白原,因此可用于探测糖基化模式改变对纤维蛋白原介导血液凝固的能力的影响。 此外,本公开的适体由于其与纤维蛋白原及其裂解产物纤维蛋白的结合而具有抗凝作用。 因此,本公开内容包括用能够特异性结合纤维蛋白原或纤维蛋白的糖基化位点的适体抑制纤维蛋白凝固的方法。 本公开还提供了包含至少一个在其上具有硼酸的核苷酸的寡核苷酸适体,其中适体能够选择性地结合纤维蛋白原或其衍生物的糖基化位点。